Endophenotypes and suicide behaviour;Endofenotipos y conductas suicidas

Actas Espanolas de Psiquiatria

Volumn 39, Issue 1, 2011, Pages 61-69

  Jimenez Trevino L ^a   Blasco Fontecilla, H ^b,e   Braquehais, M D ^c   Ceverino Dominguez, A ^d   Baca Garcia, E ^b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Centro de Salud Mental de Hortaleza   (Spain)

^e NONE   (Spain)

Author keywords

Candidates endophenotypes; Neurochemistry; Neuroimaging; Neuropsychology; Personality traits; Suicide behaviour

Indexed keywords

ENDOPHENOTYPE; GENETICS; HUMAN; MENTAL DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; SUICIDE;

ENDOPHENOTYPES; HUMANS; MENTAL DISORDERS; SUICIDE;

EID: 79960975085     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Balazic J, Marusic A. The completed suicide as interplay of genes and environment. Forensic Sci Int 2005;147 Suppl:S1-S3. (Pubitemid 40203101)
2. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, et al. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998;28(4):839-855. (Pubitemid 28393563)
3. Stefulj J, Kubat M, Balija M, Jernej B. TPH gene polymorphism and aging: indication of combined effect on the predisposition to violent suicide. Am J Med Genet B Neuropsychiatr Genet 2006;141 (2):139-141. (Pubitemid 43214788)
4. Turecki G, Zhu Z, Tzenova J, Lesage A, Seguin M, Tousignant M, et al. TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry 2001;6(1):98-102. (Pubitemid 32096073)
5. Roy A, Hu XZ, Janal MN, Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007;32(9):2046-2052. (Pubitemid 47258524)
6. Wasserman D, Geijer T, Sokolowski M, Frisch A, Michaelovsky E, Weizman A, et al. Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage. Eur Neuropsychopharmacol 2007;17(3):230-223.
7. Helbecque N, Sparks DL, Hunsaker JC, III, Amouyel P. The serotonin transporter promoter polymorphism and suicide. Neurosci Lett 2006;400(1-2):13-15.
8. Courtet P, Picot MC, Bellivier F, Torres S, Jollant F, Michelon C, et al. Serotonin transporter gene may be involved in shortterm risk of subsequent suicide attempts. Biol Psychiatry 2004;55(1):46-51. (Pubitemid 38045432)
9. Baca-Garcia E, Vaquero C, Diaz-Sastre C, Saiz-Ruiz J, Fernandez-Piqueras J, de Leon J. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002;26(5):692-695. (Pubitemid 34260988)
10. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002;13(9):1195-1198. (Pubitemid 34722052)
11. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002 ;159(3) :419-429. (Pubitemid 34184737)
12. Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 1993;614(1-2):37-44. (Pubitemid 23181149)
13. Owen F, Cross AJ, CrowTJ, Deakin JF, Ferrier IN, Lofthouse R, et al. Brain 5-HT-2 receptors and suicide. Lancet 1983;2(8361):1256.
14. Hsiung SC, Adlersberg M, Arango V, Mann JJ, Tamir H, Liu KP. Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 2003;87(1):182-194. (Pubitemid 37210652)
15. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994;35(7):457-463.
16. Persson ML, Geijer T, Wasserman D, Rockah R, Frisch A, Michaelovsky E, et al. Lack of association between suicide attempt and a polymorphism at the dopamine receptor D4 locus. Psychiatr Genet 1999;9(2):97-100.
17. Pitchot W, Hansenne M, Gonzalez MA, Pinto E, Reggers J, Fuchs S, et al. Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology 2001 ;26(7):689-696. (Pubitemid 32738993)
18. De L, V, Tharmalingam S, Sicard T, Kennedy J L Gene-gene interaction between MAOA and COMT in suicidal behavior. Neurosci Lett 2005;383(1-2):151-154. (Pubitemid 40779973)
19. Nolan KA, Volavka J, Czobor P, Cseh A, Lachman H, Saito T, et al. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr Genet 2000;10(3):117-124. (Pubitemid 32095325)
20. Savitz JB, Cupido CL, Ramesar RS. Trends in suicidology: personality as an endophenotype for molecular genetic investigations. PLoS Med 2006;3(5):e107.
21. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156(2):181-189. (Pubitemid 29077107)
22. Graff-Guerrero A, de la Fuente C, Camarena B, Aguilar A, Fresan A, Apiquian R, et al. Diferencias del metabolismo en estructuras límbicas de acuerdo a la variación alélica del polimorfismo 5HTTLPR del gen al transportador de serotonina: Un estudio piloto con PET. Salud Mental 2004;27(1):11-21. (Pubitemid 38528675)
23. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003 ; 160(4) :636-645. (Pubitemid 41079594)
24. Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci 1997;836:288-301. (Pubitemid 28044031)
25. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4(10):819-828. (Pubitemid 37314404)
26. Fergusson DM, Woodward U, Horwood U. Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood. Psychol Med 2000;30(1):23-39. (Pubitemid 30099115)
27. Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF, Burke A, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004; 161 (8):1433-1441. (Pubitemid 38989097)
28. Baca-Garcia E, Diaz-Sastre C, Garcia RE, Blasco H, Braquehais CD, Oquendo MA, et al. Suicide attempts and impulsivity. Eur Arch Psychiatry Clin Neurosci 2005;255(2):152-156. (Pubitemid 40558608)
29. Paaver M, Nordquist N, Parik J, Harro M, Oreland L, Harro J. Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology (Berl) 2007;194(4):545-554. (Pubitemid 47492997)
30. Volavka J, Bilder R, Nolan K. Catecholamines and Aggression: The Role of COMT and MAO Polymorphisms. Ann N Y Acad Sci 2004;1036:393-398. (Pubitemid 40576108)
31. Reist C, Mazzanti C, Vu R, Fujimoto K, Goldman D. Interrelationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr. Mol Psychiatry 2004;9(9):871-878. (Pubitemid 39294643)
32. Giegling I, Hartmann AM, Moller HJ, Rujescu D. Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 2006;96(1-2):75-81. (Pubitemid 44548047)
33. Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, Turecki G. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am J Med Genet B Neuropsychiatr Genet 2007;144(8):996- 1002. (Pubitemid 350207772)
34. Turecki G. Dissecting the suicide phenotype: the role of impulsiveaggressive behaviours. J Psychiatry Neurosci 2005;30(6):398-408. (Pubitemid 41812486)
35. Roy A. Family history of suicide and neuroticism: a preliminary study. Psychiatry Res 2002;110(1):87-90. (Pubitemid 34451100)
36. Baud P. Personality traits as intermediary phenotypes in suicidal behavior: genetic issues. Am J Med Genet C Semin Med Genet 2005;133(1):34-42. (Pubitemid 40194127)
37. Beautrais AL, Joyce PR, Mulder RT. Personality traits and cognitive styles as risk factors for serious suicide attempts among young people. Suicide Life Threat Behav 1999;29(1):37-47. (Pubitemid 29203237)
38. Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, Suhara T. Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry 2007;62(6):588-92. (Pubitemid 47314374)
39. Munafo MR, Clark TG, Roberts KH, Johnstone EC. Neuroticism mediates the association of the serotonin transporter gene with lifetime major depression. Neuropsychobiology 2006;53(1):1-8. (Pubitemid 43254170)
40. Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J, Gleiberman L, et al. Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry 2004;55(3):244-9. (Pubitemid 38117159)
41. Hettema JM, An SS, van den Oord EJ, Neale MC, Kendler KS, Chen X. Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 2007.
42. Reif A, Lesch KP. Toward a molecular architecture of personality. Behav Brain Res 2003;139(1-2):1-20. (Pubitemid 36298488)
43. Van Gestel S, Van Broeckhoven C. Genetics of personality: are we making progress? Mol Psychiatry 2003;8(10):840-52. (Pubitemid 37346539)
44. Gonda X, Bagdy G. [Relationship between serotonin transporter gene 5HTTLPR polymorphism and the symptoms of neuroticism in a healthy population], Psychiatr Hung 2006;21(5):379-85.
45. Deary IJ, Battersby S, Whiteman MC, Connor JM, Fowkes FG, Harmar A. Neuroticism and polymorphisms in the serotonin transporter gene. Psychol Med 1999;29(3):735-9. (Pubitemid 29261362)
46. Willis-Owen SA, Turri MG, Munafo MR, Surtees PG, Wainwright NW, Brixey RD, et al. The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association. Biol Psychiatry 2005;58(6):451-456. (Pubitemid 41393607)
47. Jollant F, Bellivier F, Leboyer M, Astruc B, Torres S, Verdier R, et al. Impaired decision making in suicide attempters. Am J Psychiatry 2005;162(2):304-10. (Pubitemid 40216211)
48. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 2003;28(1):153-162.
49. Whitaker-Azmitia PM, Molino U, Caruso J, Shemer AV. Serotonergic agents restore appropriate decision-making in neonatal rats displaying dopamine D1 receptor-mediated vacillatory behavior. Eur J Pharmacol 1990;180(2-3):305-9. (Pubitemid 20170867)
50. Clark L, Cools R, Robbins TW. The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 2004;55(1):41-53. (Pubitemid 38591429)
51. Fellows LK. The role of orbitofrontal cortex in decision making: a component process account. Ann N Y Acad Sci 2007;1121:421-430.
52. Wallis JD. Orbitofrontal cortex and its contribution to decisionmaking. Annu Rev Neurosci 2007;30:31-56. (Pubitemid 47218750)
53. Frank MJ, Claus ED. Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol Rev 2006;113(2):300-326. (Pubitemid 43815199)
54. Bechara A. The role of emotion in decision-making: evidence from neurological patients with orbitofrontal damage. Brain Cogn 2004;55(1):30-40. (Pubitemid 38591428)
55. Roiser JP, Rogers RD, Cook U, Sahakian BJ. The effect of polymorphism at the serotonin transporter gene on decisionmaking, memory and executive function in ecstasy users and controls. Psychopharmacology (Berl) 2006; 188(2):213-227. (Pubitemid 44371159)
56. Jollant F, Buresi C, Guillaume S, Jaussent I, Bellivier F, Leboyer M, et al. The influence of four serotonin-related genes on decisionmaking in suicide attempters. Am J Med Genet B Neuropsychiatr Genet 2007;144(5) :615-624. (Pubitemid 47077145)
57. Raust A, Slama F, Mathieu F, Roy I, Chenu A, Koncke D, et al. Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med 2007;37(3):411-419.
58. Keilp JG, Sackeim HA, Brodsky BS, Oquendo MA, Malone KM, Mann JJ. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001 ;158(5):735-741. (Pubitemid 32429841)
59. LeGris J, van Reekum R. The neuropsychological correlates of borderline personality disorder and suicidal behaviour. Can J Psychiatry 2006;51(3):131-142.
60. Lipsky RH, Sparling MB, Ryan LM, Xu K, Salazar AM, Goldman D, et al. Association of COMT Val 158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci 2005;17(4):465-471. (Pubitemid 41790045)
61. Reuter M, Ott U, Vaitl D, Hennig J. Impaired executive control is associated with a variation in the promoter region of the tryptophan hydroxylase 2 gene. J Cogn Neurosci 2007;19(3):401-408. (Pubitemid 46393568)
62. de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci 2005; 17(7):1018-1025. (Pubitemid 41045575)
63. Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K, et al. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 2007;164(1 ):142-149. (Pubitemid 46154793)
64. Alfimova MV, Golimbet VE, Gritsenko IK, Lezheiko TV, Abramova LI, Strel'tsova MA, et al. Dopamine system genes interaction and neurocognitive traits in patients with schizophrenia, their relatives and healthy controls from general population. Zh Nevrol Psikhiatr Im S S Korsakova 2006;106(7):57-63. (Pubitemid 44384559)
65. Asberg M, Nordstrom P, Traskman-Bendz L Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 1986;487:243-255.
66. Roy A, De Jong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 1989;46(7):609-612. (Pubitemid 19180339)
67. Nordstrom P, Samuelsson M, Asberg M,Traskman-Bendz L, Aberg- Wistedt A, Nordin C, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24(1):1-9. (Pubitemid 24116677)
68. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 1985;71(3):230-236.
69. Cremniter D, Jamain S, Kollenbach K, Alvarez JC, Lecrubier Y, Gilton A, et al. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiatry 1999;45(12):1572-1579. (Pubitemid 29294102)
70. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 2006;9(4):465-474. (Pubitemid 43979707)
71. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 2005;62(10):1109-1118. (Pubitemid 41396936)
72. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ et al. Serotonin-related gene polymorphismsand central nervous system serotonin function. Neuropsychopharmacology 2003;28(3):533-541.
73. Bertolino A, Arciero G, Rubino V, Latorre V, De Candia M, Mazzola V, et al. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry 2005;57(12):1517-1525. (Pubitemid 40805381)
74. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005;62(2): 146-152. (Pubitemid 40189130)
75. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297(5580):400-403. (Pubitemid 34790769)
76. Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2007;61(8):1011-1014. (Pubitemid 46482463)
77. Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004;55(10):1023-1030. (Pubitemid 38581918)
78. Monkul ES, Hatch JP, Nicoletti MA, Spence S, Brambilla P, Laeerda AL, et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry 2007;12(4):360-366. (Pubitemid 46496831)
79. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003 ;60( 1 ) : 14-22. (Pubitemid 36070860)
80. Silverman MM, Berman AL, Sanddal ND, O'Carroll PW, Joiner TE. Rebuilding the Tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors. Suicide Life Threat Behav 2007;37(3):248-263. (Pubitemid 46974966)